drugset / Trial / NCT03764007

18F-Fluorocholine for the Detection of Parathyroid Adenomas

NCT03764007

Phase 2/3 Completed 98 enrolled Thomas Hope
NaSingle-groupOpen-labelDiagnostic

Summary

The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.

Timeline

Start
2016-09-21
Primary completion
2021-05-31
Completion
2021-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorocholine Diagnostic / imaging agent Intravenous